scholarly article | Q13442814 |
P356 | DOI | 10.5414/CP202017 |
P698 | PubMed publication ID | 24755129 |
P2093 | author name string | Kathleen Butler | |
Renli Teng | |||
P433 | issue | 6 | |
P921 | main subject | pharmacokinetics | Q323936 |
pharmacodynamics | Q725307 | ||
P304 | page(s) | 478-491 | |
P577 | publication date | 2014-06-01 | |
P1433 | published in | International Journal of Clinical Pharmacology and Therapeutics | Q15751305 |
P1476 | title | Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers | |
P478 | volume | 52 |
Q90076389 | Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study |
Q49540317 | Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review |
Q38243032 | Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. |
Q38380508 | Genotyping-guided approach versus the conventional approach in selection of oral P2Y12 receptor blockers in Chinese patients suffering from acute coronary syndrome |
Q58763923 | Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention |
Q37198888 | Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial |
Q90369202 | Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study |
Q42023858 | Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease |
Q42694846 | Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects |
Q64079786 | Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects |
Q87951495 | Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers |
Q52682104 | Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study. |
Q27006031 | Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update |
Search more.